Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trialCraig M. McDonald, Laura Brown, Jonathan H. Soslow et al.|The Lancet|2026Cited by 0